Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
NEUROCRINE BIOSCIENCES INC | Director | Common Stock | 37.5K | $5.5M | $146.69 | Aug 15, 2024 | Direct |
NEUROCRINE BIOSCIENCES INC | Director | Restricted Stock Unit | 2.87K | $407K | $141.90 | May 22, 2024 | Direct |
FATE THERAPEUTICS INC | Director | Stock Option (Right to Buy) | 40K | $109K | $2.73 | Jun 7, 2024 | Direct |
Regulus Therapeutics Inc. | Director | Stock Option (Right to Buy) | 60K | May 20, 2024 | Rastetter Family Trust | ||
Dare Bioscience, Inc. | Director | Stock Option (right to buy) | 40K | Jun 5, 2024 | Direct | ||
NEUROCRINE BIOSCIENCES INC | Director | Non-Qualified Stock Option | 0 | $79.02 | Jan 2, 2024 | Direct |